Results 101 to 110 of about 633,166 (162)

Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients. [PDF]

Biomark Res
Grauers Wiktorin H, Ekström-Rydén V, Ek I, Eriksson E, Lövgren T, Bernedal Nordström C, Sandin LC, Patel MR, Hamid O, Ullenhag G, Loskog A.   +10 more
europepmc   +1 more source

Type I interferons in bacterial diseases: myeloid cells at the crossroads of protection and pathology. [PDF]

Front Immunol
Lyadova I.
europepmc   +1 more source

Mitochondrial dysfunction in myeloid cells: a central deficit in autoimmune diseases. [PDF]

Trends Immunol
Kwong CJ, Kaplan MJ.
europepmc   +1 more source

Remethylation of Dnmt3a−/− hematopoietic cells is associated with partial correction of gene dysregulation and reduced myeloid skewing [PDF]

, 2020
Bangert, Celia V., Brune, Meryl K., Chang, Gue Su, Chen, David Y., Fronick, Catrina, Fulton, Robert S., George, Daniel R., Helton, Nichole M., Hoock, Mieke, Ketkar, Shamika, Leight, Elizabeth R., Ley, Timothy J., Miller, Christopher A., Petti, Allegra A., Ramakrishnan, Sai Mukund, Smith, Amanda M., Spencer, David H., Verdoni, Angela M.   +17 more
core   +1 more source

Metastasis-promoting functions of myeloid cells. [PDF]

Cancer Metastasis Rev
Kusmartsev S.
europepmc   +1 more source

Differential roles for Irgm1 in myeloid cells for immune resistance to pathogenic bacteria. [PDF]

J Leukoc Biol
Fee BE, Fee LR, Sprouse AR, Vallance BA, Rai P, Fessler MB, Xue Y, Huang HI, Hammer GE, Taylor GA.   +9 more
europepmc   +1 more source

Dose-dependent IFN programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination. [PDF]

JCI Insight
Eryilmaz G, Yazici YY, Marches R, Mimitou EP, Kenyon-Pesce L, Handrejk K, Jangra S, Schotsaert M, García-Sastre A, Kuchel GA, Banchereau J, Ucar D.   +11 more
europepmc   +1 more source

Editorial: Myeloid cells as active players in human neurodegenerative diseases. [PDF]

Front Neurosci
Iyer AK, Moutinho M, Ayata P, Karahan H.
europepmc   +1 more source

Role of myeloid cells expressing CD169/Siglec-1 in host-pathogen interactions. [PDF]

FEMS Microbiol Rev
Ronco I, Horvat B.
europepmc   +1 more source

Stiripentol directly attenuates immunosuppression of tumor-infiltrating myeloid cells to potentiate anti-PD-1 efficacy. [PDF]

BMC Cancer
Xie Z, Wang K, Liu J, Hong Z, Jin Y, Wang L, Tachibana M, Liu J, Lin M, Shen Z, Shao J.   +10 more
europepmc   +1 more source